Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
135.62%
End price
17.10.24
€2.54
Summary
This prediction ended on 17.10.24 with a price of €2.54. The BUY prediction by krebskrebs for Cardiff Oncology Inc. saw massive gains of 135.62%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | 14.222% | 14.222% | -39.127% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
In the thread Trading Trovagene
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten